Carolyn Helms - Profile and Investment Details

Investor Profile

Carolyn Helms is a Venture Capital, Private Equity Firm based in San Francisco, California, United States with a diverse investment portfolio that includes companies such as Zavante Therapeutics, CardioDx, WelbeHealth, Velicept Therapeutics, Esperion Therapeutics, Aptus Endosystems, Cydan, Jazz Pharmaceuticals, Eargo, Orbus Therapeutics, LEXEO Therapeutics, RxSight, InfaCare Pharmaceutical, Aptinyx, Somatus, Talaris Therapeutics, KaNDy Therapeutics, Dascena, Venus Concept, Epirium Bio, Axonics Modulation Technologies, Tricida, Practice Fusion, Amphora Medical, Neurana Pharmaceuticals, Collegium Pharmaceutical, Sublimity Therapeutics, Rapid Micro Biosystems, Velomedix, Polares Medical, PixelOptics, Vera Therapeutics, Checkmate Pharmaceuticals, Vaxcyte, CuraSen Therapeutics, Civitas Therapeutics, Solta Medical, Alphaeon, Amunix, BAROnova, Poseida Therapeutics, Molecular Templates, Helomics, Sympara Medical, PreCision DermatologyTiburio Therapeutics, Corcept Therapeutics, Aimmune Therapeutics, MURJ, 89bio, Inozyme, AqueSys, Kala Pharmaceuticals, Encore Dermatology, Whitehill Technologies, Endeavor BioMedicines, . Over time, Carolyn Helms has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Carolyn Helms is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Patient Care, Health Care, Wearables, Wellness, Women Founded, Investment Management, Strategic Partnerships, Life Science, Portfolio Management, Medical Technologies, Information Technology (IT), Finance, Software, Biotechnology, Medical Devices, Podcasts, Market Research, Consumer Software, Capital Raising, Health Diagnostics, Digital Health, Regulatory Compliance, Developer Tools, Travel, Medical, Information Technology, B2B, Therapeutics, Pharmaceuticals, Healthcare Technology may find it worthwhile to explore potential connections with Carolyn Helms, as their portfolio suggests a familiarity and interest in this area.

Understanding Carolyn Helms’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.